Geoffrey Kerchner
Key Documents
Contact Information
-
Clinical Offices
NEUROSCIENCES CLINIC 300 PASTEUR DR BOSWELL BLDG RM A301 STANFORD, CA 94305 Tel Work (650) 723-6469 Fax (650) 725-0390
- Academic Offices
Personal Information EmailAlternate Contact Ana Mezynski Administrative Associate (academic) Email Tel Work (650) 736-4310Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Alzheimer's Disease
- Mild Cognitive Impairment
- Dementia
- Behavioral Neurology
- Neurodegenerative Disease
Honors and Awards
- Awardee, SINTN / Johnson & Johnson New Neurosciences Innovations Initiative (2011-2013)
- Awardee, Alzheimer's Association New Investigator Research Grant (2011-2013)
- Member, Phi Beta Kappa (1993-now)
- Member, Alpha Omega Alpha (2003-now)
- Medical Student Prize, American Academy of Neurology (2003)
Professional Education
| Fellowship: | UCSF, CA USA (2009) |
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (2008) |
| Residency: | UCSF, CA USA (2007) |
| Internship: | UCSF, CA USA (2004) |
| MD/PhD: | Washington University, Neuroscience (2003) |
Internet Links
Scientific Focus
Current Research Interests
Dr. Kerchner is a behavioral neurologist who cares for patients with Alzheimer's disease and other age-related neurodegenerative illnesses. He studies the use of ultra-high field MRI and other advanced neuroimaging technologies to reveal how these diseases affect the microscopic structure and circuitry of the brain, with the intent of creating new strategies for early diagnosis. Dr. Kerchner also supervises the participation of patients in clinical trials for Alzheimers disease.
Clinical Trials
Publications
- Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia. Expert Rev Neurother. 2011; (5): 709-17
- Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease. J Alzheimers Dis. 2011: 91-5
- Bapineuzumab. Expert Opin Biol Ther. 2010; (7): 1121-30
- Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology. 2010; (15): 1381-7
- Critical role for TARPs in early development despite broad functional redundancy. Neuropharmacology. 2009; (1): 22-9
Help